Only first intravitreal bevacizumab injection achieves statistically significant visual improvement in naïve myopic choroidal neovascularization

類似資料

• Multimodal imaging and diagnosis of myopic choroidal neovascularization in Caucasians
  著者:: Milani, Paolo, 等
  出版事項: (2016)
• Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
  著者:: Wang, Jia-Kang, 等
  出版事項: (2018)
• Combined photodynamic therapy and intravitreal bevacizumab as treatment for nonresponsive myopic choroidal neovascularization
  著者:: Chhablani, Jay Kumar
  出版事項: (2010)
• Single intravitreal ranibizumab for myopic choroidal neovascularization
  著者:: Nor-Masniwati, Saidin, 等
  出版事項: (2011)
• Prognostic factors for visual outcomes 2-years after intravitreal bevacizumab for myopic choroidal neovascularization
  著者:: Nakanishi, H, 等
  出版事項: (2011)